Search results for "Anticoagulation"
DOACs associated with lower risk of fracture than warfarin in atrial fibrillation
Patients taking apixaban, dabigatran, or rivaroxaban had lower rates of hip and vertebral fractures than those taking warfarin, with no difference seen between the direct oral anticoagulants (DOACs).
https://immattersacp.org/weekly/archives/2020/05/19/2.htm
19 May 2020
Coding for anticoagulation as tricky as managing it
Diagnosis, lab tests and management make up the three key considerations when coding for anticoagulation management through Medicare. An expert sorts out the issues and scenarios for a variety of scenarios.
https://immattersacp.org/archives/2010/05/practice.htm
1 May 2010
CDC updates guidance on COVID-19, studies show vitamins don't improve outcomes
The CDC offered new guidance on immunocompromised patients and pulse oximetry's accuracy, and recent trials showed that vitamin D, zinc, and ascorbic acid didn't help COVID-19 patients but prophylactic anticoagulation did.
https://immattersacp.org/weekly/archives/2021/02/23/1.htm
23 Feb 2021
DOACs show better safety, effectiveness than warfarin in patients with valvular afib
As a class, direct oral anticoagulants (DOACs) were associated with lower risk for ischemic stroke or systemic embolism and major bleeding events than warfarin, and results were consistent for apixaban and rivaroxaban.
https://immattersacp.org/weekly/archives/2021/03/30/1.htm
30 Mar 2021
AHA statement reviews efficacy, safety of CAM therapies in patients with heart failure
Potentially beneficial complementary and alternative medicine (CAM) therapies included omega-3 polyunsaturated fatty acids, coenzyme Q10, D-ribose, and L-carnitine, the American Heart Association (AHA) said.
https://immattersacp.org/weekly/archives/2022/12/13/1.htm
13 Dec 2022
Point-of-care screening did not affect diagnosis of afib in primary care, study finds
In a randomized trial at 16 primary care clinics in Massachusetts, rates of new afib diagnosis at one year were 1.72% with afib screening of older patients using a single-lead electrocardiogram versus 1.59% with usual care.
https://immattersacp.org/weekly/archives/2022/03/08/1.htm
8 Mar 2022
Non-vitamin K oral anticoagulants appear superior to vitamin K antagonists in early-stage CKD
An accompanying editorial said that the current review supports a superior benefit profile of non-vitamin K oral anticoagulants (NOACs) in patients with atrial fibrillation and early-stage chronic kidney disease (CKD).
https://immattersacp.org/weekly/archives/2019/07/16/2.htm
16 Jul 2019
New drugs could improve anticoagulation rates
Dabigatran and rivaroxaban spare patients the need for regular blood checks, but warfarin is less expensive and has an antidote to reverse bleeding, if needed. Does the convenience of the new generation of drugs and the potential to increase compliance with therapy outweigh their downsides?.
https://immattersacp.org/archives/2012/04/anticoagulation.htm
1 Apr 2012
Latest Curbsiders podcast episode features tips in perioperative medication management
Avital Y. O’Glasser, MD, FACP, covers perioperative anticoagulation, why “bridging is dead,” aspirin, dual antiplatelet therapy, and much more.
https://immattersacp.org/weekly/archives/2019/09/24/4.htm
24 Sep 2019
IDSA offers criteria on testing for COVID-19; new research looks at clots, treatments
The Infectious Diseases Society of America (IDSA) released guidance for COVID-19 testing among inpatients and outpatients, while studies offered further support for anticoagulation but showed no benefit from hydroxychloroquine or lopinavir-ritonavir.
https://immattersacp.org/weekly/archives/2020/05/12/1.htm
12 May 2020